Serveur d'exploration sur la glutarédoxine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Interactions of platinum complexes with thioltransferase(glutaredoxin), in vitro.

Identifieur interne : 001300 ( Main/Exploration ); précédent : 001299; suivant : 001301

Interactions of platinum complexes with thioltransferase(glutaredoxin), in vitro.

Auteurs : W W Wells [États-Unis] ; P A Rocque ; D P Xu ; Y. Yang ; T L Deits

Source :

RBID : pubmed:1953747

Descripteurs français

English descriptors

Abstract

Under anaerobic conditions, recombinant pig liver thioltransferase (glutaredoxin)(TT, GRX) (EC 1.8.4.1) was strongly inhibited by cis and carbo-platin and somewhat less sensitive to trans-platin, in vitro. By extrapolation to total inhibition, the ratio of platinum drug/thioltransferase was approximately 1.0 for cis and carbo-platin, but greater than 1.0 for trans-platin. When thioltransferase was not reduced, inhibition by preincubation with the platinum complexes required molar excesses of 1,300 and 675 to one for cis-platin and trans-platin, respectively or 400-500 microM for 50% inhibition. The inhibition of thioltransferase at high drug concentrations in the presence of oxygen was associated with cross-linking of monomers into dimers within 5 min and, in the case of cis-platin treatment, to trimers in 20 min incubation.

DOI: 10.1016/s0006-291x(05)81127-1
PubMed: 1953747


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Interactions of platinum complexes with thioltransferase(glutaredoxin), in vitro.</title>
<author>
<name sortKey="Wells, W W" sort="Wells, W W" uniqKey="Wells W" first="W W" last="Wells">W W Wells</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Biochemistry, Michigan State University, East Lansing 48824.</nlm:affiliation>
<orgName type="university">Université d'État du Michigan</orgName>
<country>États-Unis</country>
<placeName>
<settlement type="city">East Lansing</settlement>
<region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rocque, P A" sort="Rocque, P A" uniqKey="Rocque P" first="P A" last="Rocque">P A Rocque</name>
</author>
<author>
<name sortKey="Xu, D P" sort="Xu, D P" uniqKey="Xu D" first="D P" last="Xu">D P Xu</name>
</author>
<author>
<name sortKey="Yang, Y" sort="Yang, Y" uniqKey="Yang Y" first="Y" last="Yang">Y. Yang</name>
</author>
<author>
<name sortKey="Deits, T L" sort="Deits, T L" uniqKey="Deits T" first="T L" last="Deits">T L Deits</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1991">1991</date>
<idno type="RBID">pubmed:1953747</idno>
<idno type="pmid">1953747</idno>
<idno type="doi">10.1016/s0006-291x(05)81127-1</idno>
<idno type="wicri:Area/Main/Corpus">001291</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001291</idno>
<idno type="wicri:Area/Main/Curation">001291</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001291</idno>
<idno type="wicri:Area/Main/Exploration">001291</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Interactions of platinum complexes with thioltransferase(glutaredoxin), in vitro.</title>
<author>
<name sortKey="Wells, W W" sort="Wells, W W" uniqKey="Wells W" first="W W" last="Wells">W W Wells</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Biochemistry, Michigan State University, East Lansing 48824.</nlm:affiliation>
<orgName type="university">Université d'État du Michigan</orgName>
<country>États-Unis</country>
<placeName>
<settlement type="city">East Lansing</settlement>
<region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rocque, P A" sort="Rocque, P A" uniqKey="Rocque P" first="P A" last="Rocque">P A Rocque</name>
</author>
<author>
<name sortKey="Xu, D P" sort="Xu, D P" uniqKey="Xu D" first="D P" last="Xu">D P Xu</name>
</author>
<author>
<name sortKey="Yang, Y" sort="Yang, Y" uniqKey="Yang Y" first="Y" last="Yang">Y. Yang</name>
</author>
<author>
<name sortKey="Deits, T L" sort="Deits, T L" uniqKey="Deits T" first="T L" last="Deits">T L Deits</name>
</author>
</analytic>
<series>
<title level="j">Biochemical and biophysical research communications</title>
<idno type="ISSN">0006-291X</idno>
<imprint>
<date when="1991" type="published">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aerobiosis (MeSH)</term>
<term>Anaerobiosis (MeSH)</term>
<term>Animals (MeSH)</term>
<term>Antineoplastic Agents (pharmacology)</term>
<term>Carboplatin (pharmacology)</term>
<term>Cisplatin (pharmacology)</term>
<term>Glutaredoxins (MeSH)</term>
<term>Kinetics (MeSH)</term>
<term>Liver (enzymology)</term>
<term>Macromolecular Substances (MeSH)</term>
<term>Molecular Weight (MeSH)</term>
<term>Oxidoreductases (antagonists & inhibitors)</term>
<term>Protein Binding (MeSH)</term>
<term>Protein Disulfide Reductase (Glutathione) (MeSH)</term>
<term>Recombinant Proteins (metabolism)</term>
<term>Swine (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Anaérobiose (MeSH)</term>
<term>Animaux (MeSH)</term>
<term>Antinéoplasiques (pharmacologie)</term>
<term>Aérobiose (MeSH)</term>
<term>Carboplatine (pharmacologie)</term>
<term>Cinétique (MeSH)</term>
<term>Cisplatine (pharmacologie)</term>
<term>Foie (enzymologie)</term>
<term>Glutarédoxines (MeSH)</term>
<term>Liaison aux protéines (MeSH)</term>
<term>Masse moléculaire (MeSH)</term>
<term>Oxidoreductases (antagonistes et inhibiteurs)</term>
<term>Protein-disulfide reductase (glutathione) (MeSH)</term>
<term>Protéines recombinantes (métabolisme)</term>
<term>Structures macromoléculaires (MeSH)</term>
<term>Suidae (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Oxidoreductases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antineoplastic Agents</term>
<term>Carboplatin</term>
<term>Cisplatin</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Oxidoreductases</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Foie</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Liver</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Protéines recombinantes</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antinéoplasiques</term>
<term>Carboplatine</term>
<term>Cisplatine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aerobiosis</term>
<term>Anaerobiosis</term>
<term>Animals</term>
<term>Glutaredoxins</term>
<term>Kinetics</term>
<term>Macromolecular Substances</term>
<term>Molecular Weight</term>
<term>Protein Binding</term>
<term>Protein Disulfide Reductase (Glutathione)</term>
<term>Swine</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Anaérobiose</term>
<term>Animaux</term>
<term>Aérobiose</term>
<term>Cinétique</term>
<term>Glutarédoxines</term>
<term>Liaison aux protéines</term>
<term>Masse moléculaire</term>
<term>Protein-disulfide reductase (glutathione)</term>
<term>Structures macromoléculaires</term>
<term>Suidae</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Under anaerobic conditions, recombinant pig liver thioltransferase (glutaredoxin)(TT, GRX) (EC 1.8.4.1) was strongly inhibited by cis and carbo-platin and somewhat less sensitive to trans-platin, in vitro. By extrapolation to total inhibition, the ratio of platinum drug/thioltransferase was approximately 1.0 for cis and carbo-platin, but greater than 1.0 for trans-platin. When thioltransferase was not reduced, inhibition by preincubation with the platinum complexes required molar excesses of 1,300 and 675 to one for cis-platin and trans-platin, respectively or 400-500 microM for 50% inhibition. The inhibition of thioltransferase at high drug concentrations in the presence of oxygen was associated with cross-linking of monomers into dimers within 5 min and, in the case of cis-platin treatment, to trimers in 20 min incubation.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">1953747</PMID>
<DateCompleted>
<Year>1991</Year>
<Month>12</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>06</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0006-291X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>180</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1991</Year>
<Month>Oct</Month>
<Day>31</Day>
</PubDate>
</JournalIssue>
<Title>Biochemical and biophysical research communications</Title>
<ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation>
</Journal>
<ArticleTitle>Interactions of platinum complexes with thioltransferase(glutaredoxin), in vitro.</ArticleTitle>
<Pagination>
<MedlinePgn>735-41</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Under anaerobic conditions, recombinant pig liver thioltransferase (glutaredoxin)(TT, GRX) (EC 1.8.4.1) was strongly inhibited by cis and carbo-platin and somewhat less sensitive to trans-platin, in vitro. By extrapolation to total inhibition, the ratio of platinum drug/thioltransferase was approximately 1.0 for cis and carbo-platin, but greater than 1.0 for trans-platin. When thioltransferase was not reduced, inhibition by preincubation with the platinum complexes required molar excesses of 1,300 and 675 to one for cis-platin and trans-platin, respectively or 400-500 microM for 50% inhibition. The inhibition of thioltransferase at high drug concentrations in the presence of oxygen was associated with cross-linking of monomers into dimers within 5 min and, in the case of cis-platin treatment, to trimers in 20 min incubation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wells</LastName>
<ForeName>W W</ForeName>
<Initials>WW</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, Michigan State University, East Lansing 48824.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rocque</LastName>
<ForeName>P A</ForeName>
<Initials>PA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>D P</ForeName>
<Initials>DP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Deits</LastName>
<ForeName>T L</ForeName>
<Initials>TL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CA-51972</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Biochem Biophys Res Commun</MedlineTA>
<NlmUniqueID>0372516</NlmUniqueID>
<ISSNLinking>0006-291X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054477">Glutaredoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D046911">Macromolecular Substances</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>14913-33-8</RegistryNumber>
<NameOfSubstance UI="C034697">transplatin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>BG3F62OND5</RegistryNumber>
<NameOfSubstance UI="D016190">Carboplatin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.-</RegistryNumber>
<NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.8.4.2</RegistryNumber>
<NameOfSubstance UI="D011490">Protein Disulfide Reductase (Glutathione)</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>Q20Q21Q62J</RegistryNumber>
<NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000332" MajorTopicYN="N">Aerobiosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000693" MajorTopicYN="N">Anaerobiosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016190" MajorTopicYN="N">Carboplatin</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054477" MajorTopicYN="N">Glutaredoxins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D046911" MajorTopicYN="N">Macromolecular Substances</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011490" MajorTopicYN="Y">Protein Disulfide Reductase (Glutathione)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1991</Year>
<Month>10</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1991</Year>
<Month>10</Month>
<Day>31</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1991</Year>
<Month>10</Month>
<Day>31</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">1953747</ArticleId>
<ArticleId IdType="pii">S0006-291X(05)81127-1</ArticleId>
<ArticleId IdType="doi">10.1016/s0006-291x(05)81127-1</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Michigan</li>
</region>
<settlement>
<li>East Lansing</li>
</settlement>
<orgName>
<li>Université d'État du Michigan</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Deits, T L" sort="Deits, T L" uniqKey="Deits T" first="T L" last="Deits">T L Deits</name>
<name sortKey="Rocque, P A" sort="Rocque, P A" uniqKey="Rocque P" first="P A" last="Rocque">P A Rocque</name>
<name sortKey="Xu, D P" sort="Xu, D P" uniqKey="Xu D" first="D P" last="Xu">D P Xu</name>
<name sortKey="Yang, Y" sort="Yang, Y" uniqKey="Yang Y" first="Y" last="Yang">Y. Yang</name>
</noCountry>
<country name="États-Unis">
<region name="Michigan">
<name sortKey="Wells, W W" sort="Wells, W W" uniqKey="Wells W" first="W W" last="Wells">W W Wells</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001300 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001300 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    GlutaredoxinV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:1953747
   |texte=   Interactions of platinum complexes with thioltransferase(glutaredoxin), in vitro.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:1953747" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GlutaredoxinV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 15:13:42 2020. Site generation: Wed Nov 18 15:16:12 2020